Pediatric Arm Function Test: reliability and validity for assessing more-affected arm motor capacity in children with cerebral palsy.
Pediatric Arm Function Test: reliability and validity for assessing more-affected arm motor capacity in children with cerebral palsy.
复制标题
儿科手臂功能测试：评估脑瘫儿童受影响较大的手臂运动能力的可靠性和有效性。
DOI：
10.1097/phm.0b013e318269ec76
复制
发表时间：
2012-12
影响因子：
3
通讯作者：
Barman J
中科院分区：
文献类型：
--
作者：
Uswatte G;Taub E;Griffin A;Rowe J;Vogtle L;Barman J
虽然有几个有效的上肢措施在幼儿脑瘫（CP），没有一个主要评估的能力，以执行动作和任务与更多的影响arm. To解决这一需求，我们开发了小儿手臂功能测试（PAFT），其中包括行为观察儿童如何使用他们的更多的影响手臂在结构化的游戏在实验室或诊所。本文对PAFT功能能力量表的信度和效度进行了评价。在研究1中，20名年龄在2-8岁之间的CP所致广泛上肢轻偏瘫的儿童在两次间隔3周的情况下完成了PAFT。在研究2中，41名具有相似特征的2-6岁儿童完成了PAFT，并接受了反映受影响更大的手臂运动障碍严重程度的分级。在研究1中，PAFT重测信度相关系数为0.74。在研究2中，PAFT分数和损伤等级之间的强负相关（r =-0.6，p <0.001）支持收敛效度。PAFT功能能力量表是2-6岁CP儿童受影响更大的手臂运动能力的可靠和有效的测量方法。它可以用来衡量上肢神经康复的结果。
Although there are several validated upper-extremity measures in young children with cerebral palsy (CP), none primarily assess capacity to carry out actions and tasks with the more-affected arm. To address this need, we developed the Pediatric Arm Function Test (PAFT), which involves behavioral observation of how children use their more-affected arm during structured play in the laboratory or clinic. This paper evaluates the reliability and validity of the PAFT Functional Ability scale. In Study 1, 20 children between 2–8 years with a wide range of upper-extremity hemiparesis due to CP completed the PAFT on two occasions separated by three weeks. In Study 2, 41 children between 2–6 years with similar characteristics completed the PAFT and received a grade reflecting severity of more-affected arm motor impairment. In Study 1, the PAFT test-retest reliability correlation coefficient was 0.74. In Study 2, convergent validity was supported by a strong, inverse correlation (r = −0.6, p < .001) between PAFT scores and grade of impairment. The PAFT Functional Ability scale is a reliable and valid measure of more-affected arm motor capacity in children with CP between 2–6 years. It can be employed to measure upper-extremity neurorehabilitation outcome.